Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

New and experimental HIV treatments news

Show

From To
Once-daily topical tablet as effective as systemic drugs for oral thrush

A daily slow release topical oral treatment is as effective a treatment for oropharyngeal candida as systemic anti-fungal therapy in severely immunosuppressed individuals according to

Published
27 January 2004
By
Michael Carter
Atazanavir shown to boost amprenavir levels

Even before the 400% US price rise of ritonavir announced last month by Abbott, and the growing movement to boycott Abbott products both in US

Published
26 January 2004
By
Edwin J. Bernard
Leading AIDS experts criticise major US vaccine trial

US scientists and AIDS advocates yesterday called into question the US National Institutes of Health decision to proceed with trials of a controversial vaccine strategy

Published
16 January 2004
By
Keith Alcorn
Roche stalls second generation fusion inhibitor, citing formulation problems

Roche today announced that a successor to its fusion inhibitor T-20 (Fuzeon) may be much further off than expected, following the discovery that the current

Published
06 January 2004
By
Keith Alcorn
Looking forward to 2004: microbicide and ARV prevention prospects

Several would-be microbicides are due for large-scale clinical trials in 2004, testing two basic ideas about how to protect women from HIV through vaginal sex.

Published
31 December 2003
By
Julian Meldrum
Looking forward to 2004: HIV vaccine prospects

In 2003, the first preventive vaccines to go into full scale trials were shown conclusively not to work. It is unlikely that anything as clear

Published
30 December 2003
By
Julian Meldrum
Looking forward to 2004: treatment for hepatitis C

Hepatitis C treatment has moved forward subtantially in the past two years with the widespread adoption of combination therapy with pegylated interferon and ribavirin. What

Published
29 December 2003
By
Daniel Raymond
Tipranavir now available for emergency use in UK

Tipranavir, a new protease inhibitor under development by Boehringer-Ingelheim, is to be made available to any person with HIV in the UK who has a

Published
27 November 2003
By
Keith Alcorn
Tenofovir crisis appeal by European activists

The European AIDS Treatment Group has appealed to Europe's medicines licensing body to speed up access to tenofovir, the nucleotide analogue under development by Gilead

Published
05 March 2001
By
Keith Alcorn
UNMC researchers developing more effective drug delivery for HIV

Instead of multiple pills each day, patients would receive one weekly injection.

Published
01 January 1970
From
Health Canal

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.